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Abstract
To fully understand cell type identity and function in the nervous system there is a need to understand neuronal gene
expression at the level of isoform diversity. Here we applied Next Generation Sequencing of the transcriptome (RNA-Seq) to
purified sensory neurons and cerebellar granular neurons (CGNs) grown on an axonal growth permissive substrate. The goal
of the analysis was to uncover neuronal type specific isoforms as a prelude to understanding patterns of gene expression
underlying their intrinsic growth abilities. Global gene expression patterns were comparable to those found for other cell
types, in that a vast majority of genes were expressed at low abundance. Nearly 18% of gene loci produced more than one
transcript. More than 8000 isoforms were differentially expressed, either to different degrees in different neuronal types or
uniquely expressed in one or the other. Sensory neurons expressed a larger number of genes and gene isoforms than did
CGNs. To begin to understand the mechanisms responsible for the differential gene/isoform expression we identified
transcription factor binding sites present specifically in the upstream genomic sequences of differentially expressed
isoforms, and analyzed the 39 untranslated regions (39 UTRs) for microRNA (miRNA) target sites. Our analysis defines isoform
diversity for two neuronal types with diverse axon growth capabilities and begins to elucidate the complex transcriptional
landscape in two neuronal populations.
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Introduction
Next Generation sequencing applied to the transcriptome
(RNA-Seq) is a transformational technology that uncovers vast
amounts of novel information about transcript expression and
identity. With its advent the rich complexity of the mammalian
transcriptome is beginning to be fully appreciated [1–3]. The most
common ways of studying gene expression and function (knockout,
knockdown, transgenic overexpression, and microarray) have
generally been unable to distinguish between different isoforms
from a given locus, or even to reveal their number and complexity.
For example, gene knockout or knockdown may (or may not)
affect all isoforms, and overexpression experiments are generally
limited to a single ‘‘standard’’ isoform. Isoforms of the same gene
can differ in expression pattern and function. For example,
alternative splicing of the chromatin remodeling factors Brg1-
associated factors (BAF57) produces two different isoforms, one
that is glial specific and one that is neuronal specific [4]. Neural
cell adhesion molecule (NCAM) has three known isoforms and loss
of the 180 kDa version leads to changes at the neuromuscular
junction that are accompanied by motor deficits [5]. In addition to
isoforms that differ in protein coding region, changes in the UTRs
can effect isoform localization. This is illustrated by a brain
derived neurotrophic factor (BDNF) isoform that has a long 39
UTR which is necessary for localization to dendrites [6].
Systematic characterization of the identity and number of
isoforms, or the diversity of transcripts expressed from any single
transcriptional unit has not been possible without laborious
experimentation, so the structural and functional diversity of
transcripts from the vast majority of genes is not understood.
RNA-Seq has the ability to uncover details about isoform diversity
and expression levels. It offers a large dynamic range, accurate
quantification and the ability to identify the sequences of all the
RNA species within a given cell type. This information enables a
comprehensive approach to identification of the molecular
networks and regulatory mechanisms underlying transcriptional
control.
A detailed knowledge of the expression of cell specific isoforms is
crucial to understanding cellular diversity. This is especially
obvious in the nervous system, with its enormous variety of cell
types with distinct functions and characteristics. Previous RNA-
Seq studies of nervous system tissues have involved mixed
populations of neurons with other cell types [7,8]. To identify
neuronally expressed isoforms, and to relate gene expression to
neuronal type-specific properties, we applied RNA-Seq to cultured
peripheral neurons from dorsal root ganglia (DRG neurons) and to
cultured cerebellar granule neurons (CGNs). This neuronal
comparison should lend itself to the identification of isoforms
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30417and pathways pertinent to the intrinsic mechanisms underlying
axon regeneration, since DRG neurons regenerate in situations in
which central nervous system neurons, such as CGNs, do not
[9,10].
We found enormous diversity of isoform expression between
DRG neurons and CGNs, with over 8,000 differentially expressed
isoforms. We scanned the promoters and 39 UTRs of differentially
expressed isoforms for cis-elements involved in transcription
regulation and identified transcription factors (TFs) and miRNAs
potentially involved in the control of isoform specific expression.
Known interactions between predicted TFs and miRNAs were
used to generate regulatory networks that may be driving isoform
specific expression differences. Thus we have identified new
intracellular targets that may affect neuronal type specific
transcript expression.
Results
Next Generation Transcriptome Sequencing
RNA-Seq was performed on the polyadenylated fraction of
RNA isolated from DRG neurons and CGNs from postnatal day 8
mice grown on the growth permissive substrate laminin (LN).
DRG neurons were used because of their robust axonal growth in
culture, and because they represent a well-established model for
understanding axonal regeneration [9–11]. CGNs were chosen
because they can be obtained in relatively large numbers and high
purity and have been used extensively for in vitro studies of neurite
growth [12,13]. Approximately 40 million, 50 base pair sequence
fragments (‘‘reads’’) were recovered from each biological replicate
(Table 1). Read alignment, transcript assembly and expression
estimation were performed using Bowtie, Tophat and Cufflinks
software [14–16]. ,80% of all reads mapped to the mouse
reference genome (NCBI37/mm9) and over 3 million reads were
recognized as spanning a splice junction (Table 1). Estimated
normalized expression levels were reported in Fragments (aka:
reads) Per Kilobase of exon per Million mapped reads (FPKM).
There were over 50,000 transcripts mapping to annotated areas of
the genome and over 135,000 transcripts mapping to genomic
regions lacking annotation. For the purpose of this report we
focused only on transcription events at the level of known, active
loci (annotated loci, Table S1, GEO Accession #GSE33343).
The vast majority of transcripts mapping to an annotated locus
(95%) had an FPKM that was lower than 1% of the FPKM of the
highest expressed isoform (Tubb3, FPKM =,400,000+) indicat-
ing that the majority of transcripts fall into a relatively low
expression fraction. This observation is consistent with previously
described global gene expression patterns (Figure 1A; [17]). To
interpret patterns of transcript diversity within the limits of
sequencing depth achieved in this study (40 million reads/sample),
we identified a statistical cutoff for reliability of expression
measurements based on FPKM values. The Cufflinks software
produces estimates of FPKM and their 95% confidence intervals;
we classified isoforms with a lower confidence bound .0 as having
a ‘‘reliable’’ FPKM estimate and isoforms with a lower confidence
bound equal to 0 as having an ‘‘unreliable’’ FPKM estimate. We
quantified the relationship between reliability and FPKM using
data from each group of biological replicates to fit a logistic
regression function relating the probability that an isoform is
reliable to its FPKM value (Figure 1B). Based on these analyses, we
chose an FPKM threshold of 50. This threshold for FPKM
produced nearly balanced false positive and false negative
classification rates (false positive rates, ca. 0.14; false negative
rates ca. 0.19). Unreliable transcript abundance values were
considered to be not expressed for the purposes of our data
analysis. In our data set there were 36,119 distinct transcripts with
FPKM values $50 that mapped to annotated regions of the
genome.
Isoform Diversity
Because DRG neurons and CNS neurons such as CGNs are
highly distinct in their developmental origins, integration into
circuits, and axonal growth properties [18–20], one would predict
functionally important differences in their expression of genes and
gene isoforms. We found that, while 10,365 genes were expressed
by both populations of neurons, 5,328 genes were uniquely
expressed by DRG neurons, and 4,358 genes were uniquely
expressed by CGNs. One strength of RNA-Seq is the ability to
identify differential patterns of isoform expression [2]. To address
this issue, we defined isoforms as transcripts from the same gene
that differ in their transcription start site (TSS), coding DNA
sequence (CDS), and/or in the 39 untranslated region (39UTR).
The majority of annotated loci produced isoforms found in both
neuronal types (over 19,000; Table S1). Of the 19,000 shared
isoforms, over 4600 were differentially expressed (Cuffdiff; see
Materials and Methods); of these the majority were expressed
significantly higher in DRG neurons compared to CGNs
(Figure 2A; 3397 overexpressed in DRGs versus 1204 overex-
pressed in CGNs).
DRG neurons not only expressed higher levels of transcripts but
also expressed approximately 25% more unique isoforms (tran-
scripts expressed in one neuronal type but not the other). The
5328 cell type specific genes in DRG neurons produced 8483
isoforms, while CGNs had 4358 cell type specific genes that
produced 6778 isoforms. Interestingly, the isoforms produced by
DRG neurons were much more diverse, as a group, than those
produced by CGNs. For example, isoforms expressed by DRG
neurons utilized 1999 different transcription start sites (TSSs)
compared to 710 used by CGN exclusive genes. Similarly, DRG
neurons not only use a greater number of coding sequences (CDSs;
2050 vs. 747) but also a greater number of 39 UTRs (1828 vs. 676),
Table 1. Summary of the read alignment and mapping from Tophat.
Sample Reads Processed
Reads with at least one
reported alignment
Spliced
Fragments
Reads Failing
Alignment Total Alignments
DRG1 39,925,227 32,659,840 (81.80%) 3,512,810 6,903,205 (17.29%) 59,973,578
DRG2 36,127,068 29,835,103 (82.58%) 3,752,635 5,928,924 (16.41%) 49,178,992
DRG3 37,869,918 30,129,189 (79.56%) 4,296,280 7,358,428 (19.43%) 48,293,420
CGN1 41,163,218 33,827,887 (82.18%) 4,678,223 6,813,356 (16.55%) 55,644,984
CGN2 44,523,431 36,476,724 (81.93%) 4,294,769 7,590,331 (17.05%) 62,193,644
doi:10.1371/journal.pone.0030417.t001
RNA-Seq of CNS and PNS Neurons
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30417Figure 1. Patterns of transcript expression and determination of reliably expressed transcripts. A, Transcripts that occur at low
abundances are more frequent than transcripts that occur at high abundances. Power-law distribution states that the probability of gene expression
k, will decay as a power-law P(k) ‘ k
2r. This expression pattern occurs in both neuronal types. DRG R
2=0.927. CGN R
2=0.902. Axis in log scale. B,
Logistic regression relationships between ‘reliability’ of isoform expression, measured by isoform FPKM having a lower confidence limit exceeding0 ,
and log (FPKM), for DRG neurons (left) and CGNs (right).
doi:10.1371/journal.pone.0030417.g001
Figure 2. Differential isoform expression between DRGs and CGNs. A, Normalized abundances (FPKM) of isoforms in DRG neurons plotted
against abundances in CGNs. Differentially expressed isoforms are in red. The criteria for differential expression are: | ln(FPKMCGN / FPKMDRG)|.1;
p,0.05, the statistical test was deemed acceptable by Cuffdiff and FPKM .50. B, Same plot as in A except differentially expressed isoforms falling
within gene families of particular importance in neurons are indicated by different colored dots. The lines mark the efold changes of +1 and -1. C, The
number of differentially expressed isoforms is represented for each group of genes. DRG neuron isoforms are in green and CGN isoforms are in
purple. D, The number of isoforms found in common in DRG neurons and CGNs in each category. See Table 2.
doi:10.1371/journal.pone.0030417.g002
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fold increase in the number of TSS, CDS, and alternative 39UTRs
compared to transcripts found in CGNs. Thus DRG neurons not
only express more isoforms, but each isoform differs, on average,
in more positions than in CGNs.
To begin to understand the nature of the gene expression
differences between these two neuronal types, we chose 7 gene
classes relevant to neuronal functions such as cell adhesion, vesicle
transport and neurotransmitter expression (cadherins; integrins;
growth factors; ion channels; microtubule motor proteins;
neurotransmitter receptors; and structural proteins). CGNs
expressed a greater number of neurotransmitter receptor genes.
In all other categories DRG neurons expressed the largest number
of isoforms (Figure 2B, C; Table 2). Overall our data suggest that
DRG neurons have a larger transcriptional repertoire compared
to CGNs.
Isoform Variation in Regeneration-Related Genes
To evaluate the reproducibility of our results, we used qPCR to
assess gene expression from 9 genes and compared these levels to
those estimated by RNA-Seq (Tables 3 and 4). We chose amyloid
beta (A4) precursor-like protein 1 (Aplp1) and ATPase, Na+/K+
transporting, alpha 3 polypeptide (Atp1a3) because the expression of
these isoforms was estimated to be similar between the cell types;
activating transcription factor 3 (Atf3) and the phosphatase and
tensin homologue (Pten) were chosen because they gave rise to a host
of unique isoforms; tissue inhibitor of metalloproteinase 1 (Timp1),
memberRASoncogenefamily (Rab5b), gammasynuclein(Sncg),and
solute carrier organic anion transporter family, member 3a1
(Slco3a1) had high expression in DRG neurons compared to CGNs;
and CAS1 domain containing 1 (Casd1) had high expression in
CGNs compared to DRG neurons (Table S1). To characterize the
correlation between FPKM and qPCR (Figure 3A; Table 2), a
Kendall’scorrelation coefficientwascomputed,whichrangesfrom -
1t o+1 like the usual Pearson correlation coefficient, but makes
minimal distributional assumptions. The correlation coefficient is
0.525 which is statistically significant (p=0.0024). The probability
of concordance computed from tau is 0.763. Concordance between
twopairedobservations,(FPKM 1,qPCR 1)and(FPKM 2,qP CR2),
occurs when FPKM 1- FPKM 2 and qPCR 1- qPCR 2 have the
same sign, where the subscript indexes the observation. Under the
null, the probability of concordance is 0.50. All of this data supports
the idea that RNA-Seq faithfully represents transcript expression
[21].
Three of these genes, Atf3, Pten, and matrilin2 (Matn2) are
regeneration-related genes [22–24] that generate a total of 8
isoforms. A major goal of our research is to understand how
differences in gene expression confer differences in neuronal cell
type specific function; in particular, to unravel the gene expression
programs underlying axonal regeneration. Since DRG neurons
are known for their ability to rapidly regenerate axons [9,10,25],
further validation studies were performed on genes involved in this
process.
Atf3 is involved in peripheral nerve regeneration [22,26]. Four
Atf3isoforms were identified in our analysis (Figure 3B). These four
isoforms differ in TSS, and one differs in the CDS (Figure S1). To
validate their existence primers were designed to detect differences
in the TSS and to identify the predicted change in CDS in isoform
Atf3 J3. Atf3, Atf3 J1 and Atf3 J2 were amplified and validated by
sequencing (Figure 3B and data not shown). Although we
amplified an Atf3 J3 isoform containing the 4
th TSS, we were
unable to identify an Atf3 J3 sequence containing the predicted
change in CDS. Thus the four predicted TSS’s were validated but
the predicted change in CDS could not be confirmed using this
PCR based strategy.
Another gene of interest in neuronal regeneration is Pten;
conditional ablation of Pten results in impressive axonal regener-
ation in retinal ganglion, corticospinal tract, and DRG neurons
[23,27,28]. We identified 3 Pten isoforms in our analysis (Pten, Pten
J1, and Pten J2; Figure 3C). Pten J1 is identical in sequence to the
conventional Pten isoform except for a difference in TSS and a
small shift in splice site around exon 5 and 6 that is predicted to
result in a two amino acid change. Using PCR amplification and
sequencing analysis we were unable to confirm the existence of this
small shift in coding sequence (data not shown). We validated the
existence of Pten J2 through both PCR amplification and
sequencing (Figure 3C). Pten J2 has a truncated CDS, an
alternative transcription start site and a longer 39UTR compared
to the conventional Pten isoform expressed within neurons. Pten J2
Table 2. Categories of differentially expressed isoforms.
Category DRG CGN BOTH
Cadherins 13 5 51
Growth Factors 26 9 33
Integrins 7 0 10
Ion Channels 31 18 99
Microtubule Motor Proteins 22 5 38
Neurotransmitter Receptors 14 25 30
Structural Proteins 24 6 16
The number of isoforms overexpressed in DRGs or in CGNs is shown in each
column. The number in the BOTH column reflects the number of isoforms
which are expressed in both cell types (FPKM.50).
doi:10.1371/journal.pone.0030417.t002
Table 3. Genes and isoforms analyzed by qPCR.
FPKM QPCR
TIMP1 CGN/DRG 0.008111 0.013377
CASD1 CGN/DRG 1.546914 1.999634
RAB5B CGN/DRG 0.305764 0.442207
SLCO3A1 CGN/DRG 0.319529 0.088551
SNCG CGN/DRG 0.000423 0
APLP1 CGN/DRG 0.866076 0.866076
ATF3 CGN/DRG 0.048668 0.032352
ATF3 J1 CGN/ATF3 CGN 1.976821 0.146519
ATF3 J2 CGN/ATF3 CGN 1.239579 0.611443
ATF3 J3 CGN/ATF3 CGN 0.853864 0.844696
APLP1 CGN/ATP1A3 DRG 0.866076 0.860883
MATN2 J1 CGN/MATN2 CGN 0.846136 3.007829
PTEN J2 CGN/PTEN CGN 0.133626 0.139335
ATF3 J1 DRG/ATF3 DRG 0.227722 0.03412
ATF3 J2 DRG/ATF3 DRG 1.418459 0.098662
ATF3 J3 DRG/ATF3 DRG 0.1638 0.167082
PTEN J2 DRG/PTEN DRG 0.245028 0.002787
MATN2 J1 DRG/MATN2 DRG 2.453454 1.490104
The number in the FPKM column reflects the fold change for the given
comparison. The number in the QPCR column reflects the relative expression
determined using the delta, delta Ct method.
doi:10.1371/journal.pone.0030417.t003
RNA-Seq of CNS and PNS Neurons
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conventional Pten isoform, a result confirmed by qPCR analysis
(Figure 3D, E). The truncated CDS encodes a protein that lacks
the phosphatase domain but maintains an intact C-terminal
domain (Figure S2D). Available antibodies were unable to confirm
the presence of PTEN J2 protein in DRG neurons based on
distinct bands on western blots (data not shown). To begin to
understand PTEN J2 protein function, we expressed both
conventional PTEN and PTEN J2 from cDNAs (Figure S2A–C).
We hypothesized that overexpression of conventional PTEN
would suppress neurite outgrowth due to negative regulation of
phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and serine/threo-
nine protein kinase Akt, key regulators of neurite outgrowth [29]
and that overexpression of PTEN J2 could potentially act as a
dominant negative for PTEN due to the predicted lack of the
phosphatase domain (Figure S2C–D; [30]). Protein products of the
predicted size for PTEN and PTEN J2 could be detected by
Western blotting after transfection of 293T cells (Figure 3F).
Perhaps surprisingly neither overexpression of PTEN nor that of
PTEN J2 in primary cortical neurons significantly affected
neuronal morphology (Figure S2E), despite PTEN’s known role
in suppression of axon growth [31]. We conclude that overex-
pression of PTEN and PTEN J2 alone are not sufficient in primary
cortical neurons to negatively regulate PIP3 to such a degree that
Akt mediated neurite outgrowth is affected.
Binding Site Analysis Predicts Cell Type Specific
Transcriptional Networks
RNA-Seq data can be used to identify precise exon locations that
in turn allow the determination of TSSs for each expressed isoform.
Scanning individual isoform promoters for TF binding sites allows
prediction of TFs regulating specific isoforms [32]. By doing this it is
possible to uncover clusters of expressed isoforms mediated by cell-
specific factors [32–34]. Thus we identified promoter regions for
each isoform found to be overexpressed in one neuronal type
compared to the other, and then used ASAP, an online tool, to
estimate the relative abundance of TF binding sites (TFBSs) in these
two groups of promoters (compared to a ‘‘background’’ set of
randomly chosen promoters [33]. Relative abundances were
calculated for each TFBS in each of the two groups of promoters
(from transcripts overexpressed in DRG neurons or overexpressed
Table 4. Multiple transcripts were assembled by Cufflinks for many genes with known roles in axonal regeneration.
Number of:
Official Gene Symbol Isoforms TSS CDS 39UTR Reference
Adcyap1 (Pacap) 2 2 2 2 Neuroscience 151:63–73
Atf3 4 4 2 3 J Neurosci 27:7911–7920
Bex1 2 2 2 2 J Neurochem 115:910–920
Gap43 1 1 1 1 Development 128:1175–82
IL-6 1 1 1 1 J Neurosci 24:4432–43; J Biol Chem 283:416–26
Il6st (Gp130) 1 1 1 1 Neuron 64:617–623
Jun 1 1 1 1 Neuron 43:57–67
Klf4 1 1 1 1 Science 326:298–301
Klf6 1 1 1 1 Science 326:298–301
Klf7 2 2 2 2 Science 326:298–301
Lif 1 1 1 1 J Neurosci 21:7161–70
Mapk8ip1 (JIP1) 3 3 2 1 J Neurosci 30:7804–7816.
Matn2 1 1 1 1 J Cell Sci 122:995–1004
Mdk 1 1 1 1 J Neurosci Res 87:2908–2915.
Mtap1b 1 1 1 1 J Neurosci 24:7204–7213
Nosip 2 2 2 2 J Neuropathol Exp Neurol 60:411–21
Npr2 3 3 3 3 J Neurosci Res 86:3163–9
Ptprs (PtpSigma) 4 4 4 3 J Neurosci 22:5481–91; Science 326:592–596
Pten 3 3 3 3 Science 322:963–966; J Neurosci 30:9306–15
RhoA 1 1 1 1 J.Neurosci 29:15266–76
Rock2 3 3 3 3 J.Neurosci 29:15266–76
Smad1 2 2 1 1 J Neurosci 29:7116–23
Socs3 1 1 1 1 Neuron 64:617–623
Stat3 2 1 2 1 J Neurosci 26:9512–9
Stk25 (Mst3b) 2 2 2 2 Nat Neurosci 12:1407–14
Tnfrsf19 (TROY) 1 1 1 1 Neuron 45:353–359
Trpc4ap 1 1 1 1 J Biol Chem 283:416–426
The total number of transcripts expressed from each gene is in the isoform column. The total number of isoforms with: different transcription start sites (TSS), coding
DNA sequences (CDS), and 39 untranslated regions (39 UTR) is listed below the column header. The paper demonstrating a role for the gene in axonal regeneration is
listed in the Reference column.
doi:10.1371/journal.pone.0030417.t004
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PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30417in CGNs), and these values were used to develop a hierarchical
cluster of the TFBSs, in the form of a heat map (Figure 4; Table S2).
At one level on the map, TFBSs grouped into 7 clusters; TFs in
clusters I and V were enriched in DRG neuron-overexpressed
isoforms while the majority of TFs found in clusters III, VI, and VII
showed no enrichment in either group of overexpressed transcripts
(Figure 4). Interestingly, most TFBSs found to be overrepresented
within the promoters of differentially expressed isoforms were in the
promoters of DRG neuron-selective isoforms.
MicroRNA response element analysis of 39UTRs
RNA-Seq identifies not only TSSs, but also the full 59 and 39
untranslated regions (UTRs)of transcripts.The 39UTR isthoughtto
be the main target region for miRNAs, which bind to mRNAs and
mediate their degradation or inhibit their translation [34]. Since
miRNAs play important roles in cell-type definition [35–37], we
used an approach similar to that used for the TFBSs to predict
miRNAs involved inindividual isoformregulation. Using the same 2
groups of differentially expressed isoforms, we analyzed the relative
abundance of miRNA Response Elements (MRE). Since miRNA
binding generally leads to mRNA downregulation, a relative paucity
of MREs would be expected to correlate with increased activity of
the relevant miRNA on that group of transcripts.
Groupsof 39UTRs weresubmittedto TargetScan,whichallowed
us to scan for known and registered MREs [38]. Relative
abundance and frequency of miRNA target sites in the groups
were manually calculated following a model developed for TFBS
analysis [39], which underlies ASAP, and the resulting Z-scores
were used for hierarchical clustering (Figure 5; Table S3). Cluster
analysis revealed groups of co-regulated miRNAs. To facilitate
analysisofmiRNAswechosealevelofthedendogramthatdefines8
clusters. Clusters II and III contained miRNAs whose target sites
were found in low abundance in CGN-enriched 39UTRs suggesting
high miRNA activity (Figure 5). In contrast, the miRNAs in cluster
VI, VII, and VIII were found in low abundance in DRG 39UTRs,
suggesting high activity of the cognate miRNAs. Further validation
of these miRNAs in these cell types is needed to draw conclusions
about cell-type specific regulation, but the strong differences in
MRE abundance suggests that this approach can lead to the
identification of relevant miRNA targets, and that these may help
shape neuron specific isoform expression.
Using TFBS and miRNA data for network analysis
Understanding the functional nature of differential gene
expression has traditionally involved the use of Gene Ontology
but this method considers genes and is not yet implemented for
isoforms. Therefore our approach was to identify the regulatory
events directing isoform diversity. We did this by examining the
TFBSs and MREs on differentially expressed isoforms. By crossing
the TFBS data with the miRNA analysis we predicted novel
interaction networks potentially active in these neuronal types.
GeneGo MetaCore was used to generate an interaction network
between clusters I and V from the TFBS analysis (Figure 4), and
clusters II, III, VI, VII, and VIII from the miRNA analysis
Figure 3. Validation and functional testing of novel isoforms. A, Expression of 15 isoforms was assessed by qPCR in DRG neurons and CGNs.
Isoform expression was compared to the fold change in FPKM. (Relative expression and FPKM ratios in Table 3). B, C, Atf3 and Pten isoform specific
primers (bottom panels) were used on DRG cDNA and produced PCR products of the predicted sizes. B, Lane2: Atf3 cDNA (Open BioSystems); Lane3:
conventional Atf3; Lane4: Atf3 J1; Lane5: Atf2 J2; Lane 6: Atf3 J3; Lane7: no template control; Lane 8: no reverse transcription (RT) control. C, Lane2:
conventional Pten; Lane3: no template control for Pten; Lane4: no RT control for Pten; Lane5: Pten J2; Lane 6: no template control for Pten J2; Lane 7:
no RT control for Pten J2. Schematic representations of Atf3 and Pten isoforms are below each gel (not to scale). Primer positions are indicated with
colored arrows. D, The ratio of Pten J2 expression to Pten conventional + Pten J1 expression (in FPKM). The FPKMs for Pten and Pten J1 were summed
because there is no way to distinguish the isoforms by PCR. Pten J2 expression is reduced 80–90%. E, qPCR validates the reduction in Pten J2
expression. F, Western blot for PTEN (50 kD) and PTEN J2 (32 kD) confirms that both proteins can be produced from the corresponding cDNAs.
doi:10.1371/journal.pone.0030417.g003
RNA-Seq of CNS and PNS Neurons
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serum response factor (SRF; Figure 6; [40]). While this is a known
interaction, itis supportedby the predicted activity of bothmiR-499
and SRF in DRG neurons: miR-499 target site was found in high
abundance in DRG neuron 39UTRs, suggesting low activity and
SRF TFBSs are found in high abundance, suggesting high SRF
activity. Another potential miRNA-TF interaction was identified
between miR-125b and SRF (Figure 6; [41], an observation which
is yet again consistent with the predicted activity of these two
molecules; Figure 4 and 5). These two examples demonstrate that
this approach, to analyze differentially expressed isoforms for TFBS
and miRNA target sites, can associate specific TFs and miRNAs
activity previously identified in other systems to neuronal functions
or identity. We posit that the SRF may be a key transcriptional
regulator to promote axon growth. It is known that SRF mediates
NGF dependent axon growth and DRG neuron target innervation
in early development [42] and here we show that it has numerous
predicted interactions with miRNAs (Figure 6). This makes Srf a
prime candidate for activation because it has the potential to
regulate numerous genes simply by its ability to impact the
expression of multiple miRNAs in a cell type (DRG neurons)
exhibiting robust neurite growth both in vitro and in vivo after an
axonal injury. Indeed while there is no change in the expression of
serum response factor (Srf), we find that a novel isoform of serum
response factorbindingprotein(Srfbp1)issignificantlyoverexpressed
(up to 10-fold higher) in DRG neurons (Table S1). The activity of
the other TFs and miRNAs can be tested in future experiments for
their relevance in the specific cellular populations.
Discussion
In our studies we applied RNA-Seq to two neuronal
populations: cerebellar granular neurons (CGNs) and dorsal root
ganglion (DRG) neurons. While a few recent studies have utilized
RNA-Seq on nervous tissue [7,8], RNA-Seq on distinct neural
types remains largely unexplored [43]. To acquire pure cellular
populations cells were cultured in conditions such that large
numbers of nearly pure CGNs [12] and DRG neurons were
obtained (see Materials and Methods). We were able to identify
differentially expressed isoforms (Figure 2), confirm the identities
of numerous novel isoforms and validate their expression levels
(Figure 3), and perform a bioinformatic analysis to understand
isoform expression regulation (Figure 4, 5, 6).
Why is understanding isoform diversity important? It is well
accepted that genes express multiple isoforms and recently it has
been demonstrated that isoform number increases with sequencing
depth [44]. Identifying all expressed isoforms in specific cell
populations is therefore necessary to fully understand all of the
components contributing to cellular function. In addition to the
sheer number of isoforms with unknown functions, numerous
studies prove that isoforms can be functionally different [5,6]. In
our dataset two genes of interest, Atf3 and Pten produced multiple
isoforms (Figure 3). We used PCR and sequencing to confirm 3
TSSs for Atf3 (Figure S1). One alternative transcription start site in
our data was previously identified and characterized [45], but
never annotated; the fact that we found this TSS demonstrates the
reliability of this approach. Each Atf3 promoter is active under
different conditions. Atf3 J1 and J3, the two isoforms with the
lowest expression in DRG neurons, use the P1 promoter which is
primarily active in response to stress and in numerous cancers
[45], whereas the conventional Atf3 promoter (P2) typically is
reactive to mitogenic stimuli [46]. The Atf3 isoform with the
Figure 4. Hierarchical clustering of transcription factor binding
sites in differentially expressed isoforms. Heat map showing Z-
scores reflecting the frequency of binding sites for TFs found in the
promoters overexpressed for each comparison. Green indicates high
relative abundance for the TF binding site, and red low relative
abundance. Clusters I and V represent TFBSs whose binding sites are
enriched in DRGs. Cluster III, IV, VI and VII consists of TFBSs with low
abundance in all comparisons.
doi:10.1371/journal.pone.0030417.g004
Figure 5. Hierarchical clustering of miRNA target sites in the 39
UTRs of differentially expressed isoforms. Heat map representing
Z-scores derived from MRE frequency. Red indicates a frequent
appearance of the MRE (suggesting low miRNA activity in the
corresponding cell type) and green a low frequency (suggesting
possible high miRNA activity in the corresponding cell type). Cluster II
contains miRNAs with responsive elements appearing in 39UTRs of
transcripts overexpressed in DRGs. Cluster I miRNAs are present in most
of the transcripts regardless of comparison indicating these miRNAs
may not be active in neurons. Clusters VI-VIII represent miRNAs that
could be potentially active in DRG enriched transcripts due to their low
appearance in DRG 39UTRs, while Cluster II and III represent miRNAs
potentially active in CGNs. Cluster IV and V represent miRNAs with a low
abundance of target sites regardless of cell type suggesting these
miRNAs may be active in both neuronal types.
doi:10.1371/journal.pone.0030417.g005
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completely novel (Figure S1). While the CDS for these isoforms
are the same, one way to confer functional differences could be
through differential promoter regulation which could cause
functional differences simply by changing coregulated genes.
Another point of isoform diversity occurs with alterations in the
CDS and 39UTRs. Changes in CDS may lead to the most obvious
alterations in function as whole protein domains with specific
functions could be present or absent. We examined numerous
other transcripts associated with neuronal regeneration and found
that many harbored changes that would affect the CDS (Table 4).
One such validated example is the discovery of PTEN J2. PTEN
J2 uses an alternative TSS and has a longer 39 UTR compared to
the PTEN transcript expressed in these neuronal cells (Figure 3B).
The predicted open reading frame indicates that protein made
from this transcript would lack the phosphatase domain (Figure
S2). We were not able to validate the presence of endogenous
PTEN J2 using existing antibodies. This could be because
endogenous protein expression is low (consistent with the low
expression of the J2 transcript), but it is also possible that PTEN J2
exists solely as a regulatory noncoding RNA (ncRNA), which
could potentially function as a miRNA sponge to participate in the
fine regulation of the main transcript [47–49].
Why analyze differentially expressed isoforms for specific TFBSs
and for miRNA response elements? If one hopes to truly understand
the regulation driving isoform diversity, it is necessary to identify the
transcription factors and miRNAs that direct their expression. The
idea that this approach identifies novel regulatory networks is
supported by a comparison between the present study and a previous
study performed in our lab. In that study, TFBS analysis was
performed on differentially enriched genes between DRG neurons
and CGNs after subtractive hybridization and microarray analysis
[50]. Interestingly, we found only 6 TFs that overlap between the two
studies(Cepba,Irf1,Myc,Pax4,Rel,a ndTead).Somedifferencesmaybe
attributed to the TFBS matrices used. Smith et al. used TRANSFAC
to examine specific binding sites, while in this study we employed the
JASPAR database, which examines TFBS matrices. In addition,
different cutoffs for differential gene expression between the two
Figure 6. Interaction networks between TFs and miRNAs. The shortest paths algorithm was used to examine interactions between the TFs in
Clusters I and V (Figure 4) and the miRNAs in Clusters II, VI, VII, and VIII (Figure 5; GeneGo, MetaCore, Inc,). The number of steps was limited to one. All
interactions are shown. Interactions that support the findings from TFBS and miRNA clustering are indicated in bold. Green indicates activation and
red inhibition.
doi:10.1371/journal.pone.0030417.g006
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interesting to test whether the 6 TFs common to both analyses may
be network hubs driving DRG neuron specific gene expression.
In addition, network analysis could identify novel and
functionally relevant pathways. In fact, we found that numerous
interactions first identified in muscle tissue [40,41], were predicted
to be active in DRG neurons. For instance, our TFBS analysis
predicted high activity of SRF, forkhead box F2 (FOXF2) and
myocyte enhancer factor 2 (MEF2) in DRG neurons, which is
consistent with the high abundance of response elements for
miRNAs-1-2, -301 and -499 in DRG neuron-enriched transcripts
(Figure 6; [40,51,52]). Previous identification of these interactions
in muscle cells supports the existence of this network. When we
examine the expression of SRF, MEF2A, and FOXF2 in our
dataset, we find that SRFBP1 and a novel isoform of MEF2B are
significantly overexpressed in DRG neurons compared to CGNs
(Table S1), supporting the idea that they may be more active in
DRG neurons. Overall, this study profiles the isoform diversity
found in two neuronal populations, reports differential isoform
expression, and identifies potential regulatory networks active in
each population. We conclude that applying RNA-Seq to distinct
neuronal populations can uncover the rich isoform diversity that
contributes to neuronal identity and differential function.
Ethics Statement
All procedures using animals were approved by the University
of Miami Animal Care and Use Committee.
Materials and Methods
DRG and CGN Cell Culture
DRGs and CGNs were cultured from P8 C57bl/6j mice. CGNs
were isolated as previously described by our laboratory [53].
Tissue culture plate preparation was performed as previously
described [54]. From one mouse, 5610
5 cells were grown for
16hrs on tissue culture dishes coated with 100ug/mL poly-d-lysine
(Sigma-Aldrich) and 5ug/mL laminin (Trevigen, Inc.). Two
biological replicates for each CGN substrate were prepared for
RNA-Seq. For qPCR validation, three additional biological
replicates were prepared exactly as for the RNA-Seq experiment.
For DRG isolation, each ganglion was trimmed of its axons, and
then incubated in a solution of dispase (10mg/mL; Invitrogen),
trypsin (0.25%; Invitrogen), and collagenase (3000U/mL; Invitro-
gen). Fetal bovine serum was used to quench the trypsin. Cells
were centrifuged at 80G and then resuspended in L-15 media
(Invitrogen) and DNase (0.2mg/mL; Sigma Aldrich) followed by
trituration. Ganglia from two mice were combined for each
biological replicate. Three biological replicates were prepared in
total. The DRG media was prepared as previously described [50]
and supplemented with 0.05 mg/mL nerve growth factor and
10 mM5 9-fluoro-29deoxyuridine (FuDR, Sigma) to eliminate
contaminating glial cells. DRG cultures underwent three rounds
of 4-day FuDR treatment over the course of 16 days. Cell culture
purity was determined by counting the number of neuronal
specific tubulin positive cells and comparing that to number to
Hoechst positive nuclei using the Cellomics ArrayScan VTI
automated imaging system (Thermo Scientific). Cultures were
74% neuronal and examination of FPKMs for some known glial
associated genes supports that finding. The FPKMs for the two
known isoforms of glial fibrillary acidic protein were 11
(uc007lsw.1) and 32 (uc007lsx.1). The FPKM for myelin protein
zero (Mpz) isoforms was 11,252 FPKM and for myelin protein like
zero 1 and 3 the FPKMs were 115 (Mpzl1-uc007djg.1), 634
(Mpzl1-uc007djh.1), 769 (Mpzl1-uc007dji.1), 4 (Mpzl3-uc009
pfb.1), and 157 (Mpzl3-uc009pfc.1). The FPKMs for myelin basic
proteins were 2979 (Mbp- uc008ftx.1), 5471 (Mbp- uc008ftw.1),
and 10831 (Mbp- uc008ftz.1). While the FPKMs for Mpz and
Mbp appear high it is worth noting that DRG neurons have been
demonstrated to express both transcripts (Allen Institute for Brain
Science and Eurexpress).
RNA Isolation & Preparation for Next Generation
Sequencing
RNA was extracted using Trizol Reagent (Invitrogen) following
standard methodology. The RNA Integrity Number (RIN) was
greater than 9.5 for each biological replicate. Next Generation
Sequencing was performed at the Hussman Institute for Human
Genomics Sequencing Core Facility (University of Miami, Miami,
FL). RNA was prepared for Next Generation Sequencing
following the Illumina mRNA Sample Preparation Guidelines
(Illumina, Cat # RS-930-1001). Each sample was run over two
lanes and subjected to 52 sequencing cycles on the Illumina
Genome Analyzer II (Illumina). Image analysis and base calling
were performed using Genome Analyzer II Pipeline v1.5
(Illumina). Read alignment using the Efficient Large-Scale
Alignment of Nucleotide Databases (ELAND) algorithm is part
of the Illumina pipeline and standard service at the sequencing
core. 80% or more of the reads aligned to the mouse reference
genome (mm9) which is similar to what was found in our analysis
using Bowtie [15].
Bioinformatics
All of the bioinformatic analyses were run on the ‘‘Pegasus’’, a
Linux based supercomputer with 5000 central processing units
(http://www6.miami.edu/miami-magazine/featurestory2.html).
Reads alignment with Tophat and Bowtie. Raw reads
were first aligned to the mouse reference genome (assembly mm9).
For this purpose we used the Tophat software, version 1.0.13
[14,15]. Default settings were used except for the following
options: –G option which supplies Tophat with gene model
annotation (combined UCSC, Ensembl, and RefSeq annotations)
and –i 50 which sets the minimum intron length to 50. The
software works through the Bowtie fast aligner and it is able to
identify reads that entirely map to the reference genome as well as
predicting splice junctions aligning reads that span across distant
areas of the genome without any reference annotation. This
process was performed independently for each single sample. On
average 79% of reads aligned in at least one region of the reference
genome for all the samples (Table 1).
Transcript reconstruction and expression estima-
tion. Aligned reads were assembled into the different RNA-
species by the Cufflinks software (version 0.8.3). At first Cufflinks
uses the aligned reads in the dataset to describe a set of transcripts
starting from the reads that span splice-junctions. We ran this step
using a non-annotated reference genome because without an
annotation the software will assemble novel transcripts and
isoforms. After transcript assembly, normalized expression levels
are estimated and reported as FPKM (Fragments Per Kilobase of
exon per Million fragments mapped) together with confidence
intervals. A different part of the software, named Cuffcompare
(version 0.8.3) classified the reconstructed RNA-species as novel or
known according to how they map back to the provided reference
annotation [16]. Cuffcompare was run twice, first with a combined
reference GTF generated from crossing annotated transcripts
found in the UCSC Genome, the Ensembl, and the RefSeq
database. We combined three genome annotations in an effort to
minimize falsely identified novel transcripts. UCSC was used as
the base since it contained the highest number of annotated RNA
RNA-Seq of CNS and PNS Neurons
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databases were added. We reran Cuffcompare in order to improve
the accuracy of read alignment and therefore transcript expression
estimation (personal communications with Cole Trapnell). The
nature of the alignment of the reconstructed RNA-specie and the
annotated element are reported according to a code letter. For our
purposes we isolated from the output only the ‘‘=’’, ‘‘j’’ and ‘‘u’’
classes (corresponding to a ‘‘perfect match’’ to a known RNA-
molecule, new isoforms of known active locus, and to full
transcripts never identified before – see [16] for more details).
We ran Cuffcompare a 2nd time after adding annotation for
unknown and novel transcripts assembled by Cufflinks.
Differential Expression Testing. In order to determine
which isoforms were differentially expressed within the dataset we
used Cuffdiff [16]. Cuffdiff allowed the biological replicate data to
be run by Cufflinks as a group, thus enabling identification of
differentially expressed isoforms between conditions. Isoforms were
considered significant if they met Cuffdiff’s requirements to perform
a statistical test (see Materials and Methods; [16]), had a corrected
p-value ,0.05, and an absolute value of the natural log of the fold
change .1. Cuffdiff (version 0.9.3) was run using
the new combined annotation. We used the upper-quartile
normalization option to exclude reads coming from highly
expressed genes which allowed more accurate expression level
determination of transcripts expressed at low levels [55]. Cuffdiff
was run twice: the first time expression estimation was performed
separatelyfor each single sample, allowingusto assessthe variability
between biological replicates. The second run was performed using
the ‘‘biological replicates’’ option. This option gave a single
expression level per transcript per condition and allowed
differential expression testing between cell types. Cuffdiff
determined statistical significance based on the square root of the
Jensen-Shannon divergence between the relative abundance of
transcripts [16]. Significance was reported as an uncorrected p-
value, and then classified as significant/not –significant after
Benjamini-Hochberg correction of the p-value. We considered
transcripts as differentially expressed if: 1) the Jensen-Shannon test
statistic was reported, 2) the False-Discovery-Rate adjusted p value
was less than 0.05, and 3) change in relative abundance in either
direction wase-fold or greater, e is the base of the natural logarithm.
Logistic Regression Analysis
Based on the 95% confidence intervals for FPKM produced by
Cufflinks software, we distinguished more reliable from less
reliable FPKM estimates by labeling an FPKM estimate with a
lower confidence bound exceeding 0 as ‘‘reliable’’ and an FPKM
estimate with lower confidence bound of 0 as ‘‘unreliable’’. We
used these observations to fit a logistic regression function (SAS,
version 9.2) relating the probability that an isoform was reliable to
log FPKM.
Defining TSS, CDS, and 39 UTR
TSSs were defined as the beginning of the first exon. A change
in CDS was defined as any change that occurred from exon 2 to
the second to last exon when compared to the conventional
isoform. 39 UTRs were defined as the last exon. The number of
differentially expressed isoforms associated with a CDS in the
reference annotation was greater than 93% indicating that the vast
majority of transcripts analyzed in this dataset are in fact
messenger RNAs and not noncoding RNAs.
Quantitative Real Time PCR
Three additional biological replicates were created for both
DRGs and CGNs. RNA from these replicates was used as input
(450ng) for a reverse transcription reaction using oligo d(T)
primers following the manufacturer’s recommendations (Advan-
tage RT-for PCR kit, Clontech). In all cases primers designed for
qPCR spanned exon-exon boundaries. Real time PCR was
performed using 2X SYBR Green master mix (Applied BioSys-
tems) on the Gene Rotor System (Corbett Research, Qiagen).
Relative expression was calculated using the delta delta Ct method
[56]. Primer sequences can be found in Table 5.
Validation of Atf3 and Pten Isoforms
Sequences for each set of isoforms were retrieved from the
UCSC Genome Browser after uploading a user supplied GTF
with the coordinate locations of each exon in the Atf3 and Pten
isoforms. Primers for validation can be found in Table 5. PCR
results in Figure 3B-C were obtained using DRG cDNA, with
Table 5. Primer sequences used for qPCR and isoform
validation.
Gene/Isoform Primer Sequence
Product Size
(bp)
Atp1a3 59-CCCCATATCTTCTTTAGGGTCTG-39 144
59-GCAGGATAGAGAAGCCACCA-39
Aplp1 59-CCTTCAGGTGATCGAAGAGC-39 124
59-ACTGGGACCCAAGTGTTCAG-39
Atf3 59-CCAGCCACAGTCTCACTCAG-39 1435
59-CAACAGAGGATGGACGACAC-39
Atf3 J1 59-TGGAAGAGAGACTCCTCTGAACA-39 1339
59-CAACAGAGGATGGACGACAC-39
Atf3 J2 59-AGATCCAATCCCTGCCTTG-39 1289
59-CAACAGAGGATGGACGACAC-39
Atf3 J3 59-CAGACCAGACAAGAGTATGGAAGA-39 1072
59-TTTCCGGGAGTTTCATCAGA-39
Timp1 59-ATTCAAGGCTGTGGGAAATG-39 183
59-CTCAGAGTACGCCAGGGAAC-39
Sncg 59-GACCAAGGAGGGGGTTATGT-39 135
59-ACTGTGTTGACGCTGCTGAC-39
Slo3a1 59-TCTTATGCGCTGGGAGTTCT-39 106
59TGCTCCAGAACAGACAGGTG-39
Casd1 59-AGCAGCACCAGGACCTCTAA-39 114
59TCTGCTCGATTCAGGAAGGT-39
Rab5b 59-GAAGTTGCCAAAGAGCGAAC-39 220
59-CAGGGCTCAGTGTGCTGTTA-39
Matn2 J1 59-CCTGAGCCAGTCACCATAAA-39 278
59-TTTAGGCGATTTTCCAAAGC-39
Matn2 59-AGCCAACAGTGCAACATAGA-39 161
59-TTCATTTGCAACGTTCTGGA-39
Pten 59-GGATTTCCTGCAGAAAGACTTG-39 187
59-GCTGTGGTGGGTTATGGTCT-39
Pten J2 59-CACTGGCTCCAGATTGTAGG-39 244
59CGTCCCTTTCCAGCTTTACA-39
Smad1 59-CAGCGCGACCAGATCAAT-39 746
59-AGTGGTAGGGGTTGATGCAG-39
Smad1 J1 59-TTTGTTTCTGCCCTGAGCTT-39 591
59-AGTGGTAGGGGTTGATGCAG-39
doi:10.1371/journal.pone.0030417.t005
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Pten isoform over expression
Pten and Pten J2 CDS’s were cloned into a modified pAAV-MCS
plasmid (University of Miami Viral Vector Core, Miami, FL)
containing the 2A peptide (Figure S1). The 2A peptide facilitates a
ribosomal pause and thus produces two individual proteins from a
polycistronic mRNA [57]. Pten-2A-eGFP/mCherry or Pten-J2-
2A-eGFP/mCherry were transfected into HEK293 cells (Fugene,
Roche) followed by Western blotting for PTEN or PTEN J2 (Cell
Signaling, #9559). Early postnatal cortical neurons were prepared
and transfected as previously described [58]. All plasmids (DCX,
ORX1, PTEN, PTEN J2) were overexpressed from the pAAV-2A
plasmids. Transfected cortical neurons were grown for 3 days,
fixed and immunostained with Hoechst dye to mark nuclei and for
neuronal specific tubulin (mouse monoclonal antibody, produced
at the University of Miami monoclonal antibody core facility).
Neurons were grown at densities such that processes could be
accurately imaged and traced without substantial overlap between
cells. Neuronal imaging and tracing was performed using the
Cellomics ArrayScan VTI automated microscope (Thermo
Fisher). Neurite length was determined using the Neuronal
Profiling Algorithm v3.5. Data analysis was performed in Spotfire
Decision Site Software (v9.1.2, Tibco). Transfected neurons were
determined by calculating a background fluorescent intensity in
neurons that did not receive plasmid and then a threshold was set,
above which a neuron was deemed transfected [58]. The total
neurite length for transfected neurons was determined for each
plasmid condition. Dunnett’s post test was performed to determine
if there were significant differences in neurite length after
transfection. OXR1 served as the neutral control and DCX as a
positive control [58].
Transcription Factor Binding Sites Analysis
Differentially expressed transcripts were grouped according to
their expression profiles. Promoter regions -1000 to + 300 bp from
the TSS were isolated for each single transcript. We took
advantage of individual start sites as identified by sequencing to
define RNA-species specific promoters.
Matrix models for Vertebrate Transcription Factors Binding
Sites (TFBS) from the JASPAR database were then used to scan the
promoter regions [59]. The frequencies of the binding sites were
calculated as number of binding sites per base pair independently
for eachgroup and then compared to the frequencies calculatedin a
background of 5000 randomly chosen promoters to obtain the
expected frequencies. The whole analysis was performed by Asap
[33], which reported overorunderrepresentation ineachgroup as a
Z-score calculated on the basis of frequency of TFBS appearance.
We used only transcription factors with a Z-score one standard
deviation above and below the average Z-score in at least one of the
conditions to draw the heatmap.
MicroRNAs Target Site Analysis
The same groups of transcripts used for the TFBS analysis were
tested for abundance of target sites for specific miRNAs. MiRNAs
are thought to target primarily 39UTR’s of messenger RNAs
although recent reports have demonstrated that functional target
sites can be found even in the coding sequence as well as in the
59UTR of the transcripts [60,61]. We decided to test the 39UTR
as the originally identified location of miRNA targets and
therefore the one with the better characterized binding nature.
Considering the complexity of defining the exact coding sequences
and demonstrating their functionality, we defined 39UTRs as the
last exon of each transcript. MiRNA target sequences were based
on the 5.1 release of TargetScanMouse (http://www.targetscan.
org/mmu_50/; [38]). We allowed the software to recognize only
perfect match complementarities to the seed-region of each
miRNA. Three different kinds of sites are then reported: 7mer-
8m, 7mer-1A and 8mer (see [38]).
To test for significance of over or underrepresentation of target
sites in the different groups the approach described for the TFBS
analysis was used. Briefly, frequencies of target sites per base pair
were calculated for each group as well as for a background of 5000
randomly chosen 39UTRs. Frequency in each group was
compared to the frequency in the background to calculate the
expected frequency. Observed and expected frequencies were then
used to calculate a Z-score representing over or underrepresen-
tation of target sites in each individual group. This approach was
previously described by Sui and colleagues [62]. We used only
miRNAs with a Z-score +/2 1 standard deviation around the
average Z-score in at least one of the conditions to draw the
heatmap.
Supporting Information
Figure S1 Atf3 transcripts in the UCSC Genome Brows-
er. Labelsaredirectlyaboveeachtrackdisplay.Thickblackbarsare
exonsand thethinline indicates introns.Arrowsindicate direction of
transcription (Atf3 is on the minus strand). Atf3, Atf3 J1,a n dAtf3 J2
have all been reported before. Atf3 J2 is a novel isoform. In total
three promoters are active: P1, P2 and a novel promoter, P3.
(TIF)
Figure S2 Pten isoform analysis. A, B, pAAV-2A-Pten or -
Pten J2 over expression plasmids. C, The 2A peptide bridge
sequence which mediates a ribosomal pause resulting in two
independent proteins (2A bridge schematic adapted from Tang
et al., 2009). D, Pten and Pten J2 amino acid sequences were put
into protein BLAST. Pten J2 predicted protein lacks the
phosphatase domain. E, Total neurite length is not changed
compared to control (Oxr1). Doublecortin (DCX) is a positive
control as it is known to increase neurite length. ***P,0.005.
(TIF)
Table S1 Isoforms tracking file. The nearest reference ID
column refers to associated transcript ID given by UCSC Known
Genes, RefSeq, or Ensemble database. A _j indicates a novel
isoform. FPKM estimation for each individual sample with
confidence intervals is shown. The biological replicates FPKM
information was generated in the Cuffdiff run and used to
differential expression analysis.
(XLSX)
Table S2 Transcription factor names and Z-scores that
went into creating the Figure 4 heatmap. The transcription
factors are from the JASPAR database (release 10/2009). The Z-
score for each TFBS in the promoters of DRG or CGN enriched
isoforms is shown.
(XLSX)
Table S3 MiRNA names and Z-scores that went into
creating the Figure 5 heatmap. The Z-score for each TFBS
in the 39 UTRs of DRG or CGN enriched isoforms is shown.
(XLSX)
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